Los Angeles Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.5M Buy
532,646
+404,195
+315% +$41.5M 0.2% 104
2025
Q4
$15M Buy
128,451
+33,872
+36% +$3.93M 0.05% 201
2025
Q3
$12M Buy
94,579
+57,250
+153% +$6.82M 0.04% 247
2025
Q2
$4.58M Sell
37,329
-3,952
-10% -$451K 0.02% 320
2025
Q1
$4.18M Sell
41,281
-12,932
-24% -$1.26M 0.02% 316
2024
Q4
$5.01M Buy
54,213
+3,923
+8% +$385K 0.02% 328
2024
Q3
$4.86M Buy
50,290
+42,338
+532% +$3.8M 0.02% 312
2024
Q2
$682K Buy
+7,952
New +$667K ﹤0.01% 776
2023
Q2
Sell
-95,460
Closed -$5.16M 1204
2023
Q1
$5.16M Sell
95,460
-42,673
-31% -$2.48M 0.02% 342
2022
Q4
$8.26M Sell
138,133
-17,909
-11% -$974K 0.04% 306
2022
Q3
$7.06M Sell
156,042
-105,443
-40% -$5.28M 0.04% 313
2022
Q2
$11.7M Buy
261,485
+238,356
+1,031% +$12.2M 0.06% 254
2022
Q1
$1.31M Hold
23,129
0.01% 663
2021
Q4
$1.2M Sell
23,129
-294,612
-93% -$15.2M ﹤0.01% 664
2021
Q3
$19M Buy
317,741
+24,237
+8% +$1.52M 0.09% 194
2021
Q2
$18.2M Buy
+293,504
New +$19.6M 0.08% 214
2019
Q1
Sell
-88,838
Closed -$4.36M 1377
2018
Q4
$4.36M Sell
88,838
-34,725
-28% -$1.98M 0.03% 390
2018
Q3
$7.66M Sell
123,563
-48,793
-28% -$2.97M 0.04% 383
2018
Q2
$9.29M Sell
172,356
-12,243
-7% -$612K 0.05% 362
2018
Q1
$8.4M Buy
184,599
+24,017
+15% +$1.03M 0.05% 348
2017
Q4
$6.31M Buy
160,582
+13,098
+9% +$498K 0.03% 412
2017
Q3
$5.44M Sell
147,484
-13,274
-8% -$473K 0.03% 417
2017
Q2
$6.19M Sell
160,758
-38,257
-19% -$1.4M 0.04% 402
2017
Q1
$6.78M Buy
199,015
+116,111
+140% +$3.81M 0.05% 359
2016
Q4
$2.72M Buy
82,904
+9,879
+14% +$320K 0.02% 498
2016
Q3
$2.36M Sell
73,025
-36,501
-33% -$1.18M 0.02% 550
2016
Q2
$3.38M Sell
109,526
-14,324
-12% -$448K 0.03% 449
2016
Q1
$3.71M Sell
123,850
-12,082
-9% -$334K 0.03% 367
2015
Q4
$3.76M Hold
135,932
0.03% 382
2015
Q3
$4.15M Sell
135,932
-616
-0.5% -$21.4K 0.04% 379
2015
Q2
$5M Sell
136,548
-13,890
-9% -$495K 0.05% 387
2015
Q1
$5.31M Buy
150,438
+1,559
+1% +$53.4K 0.05% 363
2014
Q4
$4.55M Buy
148,879
+44,887
+43% +$1.4M 0.04% 324
2014
Q3
$3.05M Sell
103,992
-28,121
-21% -$857K 0.04% 371
2014
Q2
$3.77M Sell
132,113
-912
-0.7% -$25.4K 0.04% 386
2014
Q1
$3.8M Sell
133,025
-40,167
-23% -$1.05M 0.04% 378
2013
Q4
$4.59M Sell
173,192
-4,795
-3% -$133K 0.05% 353
2013
Q3
$4.88M Buy
177,987
+11,199
+7% +$287K 0.06% 340
2013
Q2
$3.82M Buy
+166,788
New +$3.77M 0.05% 343

Other funds holding EHC

Los Angeles Capital Management's EHC Position: Q1 2026 in Review

Los Angeles Capital Management increased its Encompass Health (EHC) stake by 315% in Q1 2026, buying an estimated $41.5M and bringing the position to 532,646 shares worth $51.5M. The position accounts for 0.2% of the portfolio, ranked #104.

Los Angeles Capital Management first reported a position in EHC in Q2 2013 and has held it in 39 quarters since. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Los Angeles Capital Management held 532,646 shares of Encompass Health worth $51.5M as of Q1 2026.
  • Los Angeles Capital Management bought 404,195 Encompass Health shares in Q1 2026, an estimated $41.5M.
  • Encompass Health made up 0.2% of Los Angeles Capital Management's portfolio in Q1 2026, its #104 holding.
  • Los Angeles Capital Management first reported a position in Encompass Health in Q2 2013 and has held it in 39 quarters since.
  • 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.